RSV severity in New Zealand 2021 and 2022: applying the WHO severity assessment framework

Q: What is the clinical evidence from this study?

Study design: Observational. Population: Respiratory Syncytial Virus (RSV). Intervention: COVID-19 pandemic measures.

David Broderick; Isabella Cheung; Janine Paynter; Jane O'Donnell; Steffen Albrecht; Nayyereh Aminisani; Adrian Trenholme; Cameron Grant; Q. Sue Huang; Nikki Turner; Catherine A. Byrnes; Peter McIntyre

doi:10.1016/j.lanwpc.2024.101221

October 1, 2024The Lancet Regional Health - Western PacificOpen Access

RSV severity in New Zealand 2021 and 2022: applying the WHO severity assessment framework

View Full Paper

Ask AI

Bookmark

Share

Key result

The provided abstract contains only background information regarding RSV activity and pandemic measures in New Zealand, with no quantitative results reported.

Key Points

To assess respiratory syncytial virus (RSV) severity using the WHO severity assessment framework following public health disruptions associated with the SARS-CoV-19 pandemic.
Applied the World Health Organization (WHO) severity assessment framework to evaluate RSV infection impact across 2021 and 2022.
Examined changes in viral transmission following widespread pandemic interventions, including border closures, social distancing, and facemask use.
RSV contributes to substantial severe respiratory disease burden during the first two years of life and marks significant respiratory deterioration in older populations.
Pandemic control measures instituted during SARS-CoV-19 produced disruptions to seasonal viral circulation that substantially exceeded the multi-year delays observed following the 2009 influenza pandemic.

Study Design

Type

Observational

PICO

P

Population

Respiratory Syncytial Virus (RSV)

E

Exposure / Comparator

COVID-19 pandemic measures

Implication

No quantitative RSV results reported; leaves open pandemic effects on New Zealand seasonality and requires full data for interpretation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Broderick et al. (2024) conducted an observational in Respiratory Syncytial Virus (RSV). COVID-19 pandemic measures was evaluated. The provided abstract contains only background information regarding RSV activity and pandemic measures in New Zealand, with no quantitative results reported.

synapsesocial.com/papers/6a9a93af0f5ad877dd71175b https://doi.org/10.1016/j.lanwpc.2024.101221

View Full Paper

Ask AI

Bookmark

Share

RSV severity in New Zealand 2021 and 2022: applying the WHO severity assessment framework

Key Points

Study Design

PICO

Implication

Discussion

Cite This Study

RSV severity in New Zealand 2021 and 2022: applying the WHO severity assessment framework

Key Points

Study Design

PICO

Implication

Discussion

Cite This Study

Keep reading

Keep reading